Satisfaction and Efficacy Outcomes When Switching from Injectable Disease-Modifying Therapies to Fingolimod in PREFERMS: Effect of Previous Treatment

被引：0
|
作者：
Hunter, Samuel F. [1 ]
Cree, Bruce A. C. [2 ]
Meng, Xiangyi [3 ]
Schofield, Lesley [3 ]
Kolodny, Scott [3 ]
Tenenbaum, Nadia [3 ]
Thomas, Florian P. P. [4 ]
机构：
[1] Adv Neurosci Inst, Franklin, TN USA
[2] UCSF Weill Inst Neurosci, San Francisco, CA USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Hackensack Univ Med Ctr, Hackensack, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P019
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF DISEASE-MODIFYING THERAPIES FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS: A SYSTEMATIC REVIEW
    Lingohr-Smith, M.
    Deitelzweig, C.
    Lin, G.
    Lin, J.
    [J]. VALUE IN HEALTH, 2021, 24 : S158 - S158
  • [42] Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab
    Pfeuffer, Steffen
    Ruck, Tobias
    Pul, Refik
    Rolfes, Leoni
    Korsukewitz, Catharina
    Pawlitzki, Marc
    Wildemann, Brigitte
    Klotz, Luisa
    Kleinschnitz, Christoph
    Scalfari, Antonio
    Wiendl, Heinz
    Meuth, Sven G.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (09): : 1007 - 1013
  • [43] Real-world effectiveness of initial treatment with newer versus injectable disease-modifying therapies in pediatric multiple sclerosis in the US
    Krysko, K. M.
    Graves, J. S.
    Rensel, M.
    Weinstock-Guttman, B.
    Rutatangwa, A.
    Aaen, G.
    Benson, L.
    Chitnis, T.
    Gorman, M.
    Goyal, M.
    Harris, Y.
    Krupp, L.
    Lotze, T.
    Mar, S.
    Moodley, M.
    Rodriguez, M.
    Rose, J.
    Schreiner, T.
    Waltz, M.
    Casper, T. C.
    Waubant, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 97 - 98
  • [44] Comparative analysis of early treatment effectiveness of first-line disease-modifying therapies and fingolimod on cognitive functions in persons with multiple sclerosis
    Yigit, P.
    Sagici, O.
    Abasiyanik, Z.
    Baba, C.
    Ozakbas, S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 566 - 567
  • [45] Switching from injectable to other Disease Modifying Therapies may improve sexual dysfunction in people with Multiple Sclerosis
    Ala, Sara
    Amirkafi, Ali
    Kohandel, Kosar
    Shahmohammadi, Sareh
    Sahraian, Mohammad Ali
    [J]. BMC NEUROLOGY, 2024, 24 (01)
  • [46] Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
    Logroscino, Giancarlo
    Imbimbo, Bruno P.
    Lozupone, Madia
    Sardone, Rodolfo
    Capozzo, Rosa
    Battista, Petronilla
    Zecca, Chiara
    Dibello, Vittorio
    Giannelli, Gianluigi
    Bellomo, Antonello
    Greco, Antonio
    Daniele, Antonio
    Seripa, Davide
    Panza, Francesco
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (09) : 1091 - 1107
  • [47] Disease activity outcomes with different washout periods after switching from natalizumab to an alternative disease-modifying therapy
    Hua, Le H.
    Harris, Haleigh
    Conway, Devon
    Hersh, Carrie M.
    [J]. JOURNAL OF NEUROLOGY, 2020, 267 (08) : 2214 - 2220
  • [48] Disease activity outcomes with different washout periods after switching from natalizumab to an alternative disease-modifying therapy
    Le H. Hua
    Haleigh Harris
    Devon Conway
    Carrie M. Hersh
    [J]. Journal of Neurology, 2020, 267 : 2214 - 2220
  • [49] Disease-Modifying Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis: A Comparison of Their Efficacy for Reducing Relapse Rate
    Lingohr-Smith, M.
    Deitelzweig, C.
    Lin, G.
    Lin, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 34 - 35
  • [50] safety and efficacy of disease modifying therapies after switching from natalizumab: a menactrims observational study
    Zeineddine, Maya
    Alroughani, Raed
    Khoury, Samia
    El Ayoubi, Nabil
    Al Mahdawi, Akram
    Al Khaboori, Jaber
    Al Asmi, Abdullah Rashid Hawaishil
    Chentouf, Amina
    Inshasi, Jihad
    Gouider, Riadh
    Mrabet, Saloua
    Shalaby, Nevin
    Massouh, Joelle
    Al-Hajje, Amal
    Salameh, Pascale
    Dimassi, Hani
    Boumediene, Farid
    Yamout, Bassem I.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 31 - 32
12345